ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Letter To Editor   
  • J Anal Bioanal Tech 2022, Vol 13(4): 453
  • DOI: 10.4172/2155-9872.1000453

The use of Bioanalysis in Medication Development and Discovery

Bezhan Chankvetadze*
Institute of Physical and Analytical Chemistry, School of Exact and Natural Sciences, Tbilisi State University, Chavchavadze Ave 3, 0179, Tbilisi, Georgia
*Corresponding Author: Bezhan Chankvetadze, Institute of Physical and Analytical Chemistry, School of Exact and Natural Sciences, Tbilisi State University, Chavchavadze Ave 3, 0179, Tbilisi, Georgia, Email: jpba_bezhan@yahoo.com

Received: 03-Apr-2022 / Manuscript No. jabt-22-62016 / Editor assigned: 05-Apr-2022 / PreQC No. jabt-22-62016(PQ) / Reviewed: 18-Apr-2022 / QC No. jabt-22-62016 / Revised: 23-Apr-2022 / Manuscript No. jabt-22-62016(R) / Published Date: 30-Apr-2022 DOI: 10.4172/2155-9872.1000453

Letter To Editor

Recent years have witnessed the introduction of many highquality review articles into the literature covering numerous scientific and technical aspects of bio analysis. Currently it’s wide accepted that bioanalysis is AN integral a part of the pharmacokinetic/ pharmacodynamics characterization of a unique chemical entity from the time of its discovery and through numerous stages of drug development, resulting in its market authorization. During this compilation, the vital bio analytical parameters and its application to drug discovery and development approaches square measure mentioned, which can facilitate within the development of safe and a lot of efficacious medicine with reduced development time and price. it’s supposed to administer some general thoughts during this space which can kind basis of a general framework on however one would approach bio analysis from origin (i.e., discovery of a lead molecule) and progressing through numerous stages of drug development [1].

Sample preparation may be a technique accustomed pack up a sample before analysis and/or to concentrate a sample to boost its detection. Once samples square measure biological fluids like plasma, humor or excreta, this method is represented as bio analytical sample preparation. The determination of drug concentrations in biological fluids yields the info accustomed perceive the time course of drug action, or PK, in animals and man and is an important part of the drug discovery and development process Sample preparation may be a technique accustomed pack up a sample before analysis and/or to concentrate a sample to boost its detection. once samples square measure biological fluids like plasma, humor or excreta, this method is represented as bio analytical sample preparation. The determination of drug concentrations in biological fluids yields the info accustomed perceive the time course of drug action, or PK, in animals and man and is an important part of the drug discovery and development method [2].

There is a general agreement that a minimum of the subsequent validation parameters ought to be evaluated for quantitative procedures: property, activity model, stability, accuracy (bias, precision) and limit of quantification. further parameters which could need to be evaluated embody LOD, recovery, dependability and strength

Repeatability means that however the tactic performs in one work and on one instrument, among a given day. Intermediate exactitude refers to however the tactic performs, each qualitatively and quantitatively, among one work, however currently from instrumentto- instrument and from daily. Finally, dependability refers to however that methodology performs from lab-to-lab, from daily, from analystto- analyst, and from instrument-to-instrument, once more in each qualitative and quantitative term. Drug discovery/design consists of identification and characterization of recent targets (enzymes or receptors), synthesis of recent lead molecules, screening of recent lead molecules for in vitro and/or in vivo biological activities, and chemistry characterization of leads. For discovery, the priority is to look at an oversized range of compounds and confirm that pharmacologically active compounds square measure best suited for drug development. In apply, once a compound is obtained that has the specified biological activity, variety of analogues or with chemicals similar compounds are going to be synthesized and tested to optimize the well-liked characteristics of the compound (a method called lead optimization). Victimization machine-driven techniques, ultrahigh turnout will be obtained by the foremost advanced laboratories and tens of thousands of compounds will be screened in someday [3,4].

Using machine-driven techniques, ultrahigh turnout will be obtained by the foremost advanced laboratories and tens of thousands of compounds will be screened in someday. within the secondary screening stage, physiochemical properties like solubility, lipophilicity and stability square measure determined by victimization octane– water partition constant and pKa. The necessity for sound bio analytical strategies is well understood and appreciated within the discovery section and through the diagnosis and clinical stages of drug development. Therefore, it’s usually accepted that sample preparation and methodology validation square measure needed to demonstrate the performance of the tactic and therefore the dependableness of the analytical results. The acceptance criteria ought to be clearly established during a validation set up, before the initiation of the validation study. The developed assay ought to be sufficiently rugged that it provides opportunities for minor modifications and/or simple adoptability to suit alternative bioanalytical desires like relevancy to a drug–drug interaction study, toxicokinetic study moreover as for characterization of the plasma levels of the metabolites. For bioanalytical liquid action strategies, sample preparation techniques, the essential validation parameters with their tips and recommended validation add drug discovery and development section are mentioned here [5,6].

References

  1. Scott RJ, Palmer J, Lewis IA, Pleasance S (1999) Determination of a ‘GW cocktail’ of cytochrome P450 probe substrates and their metabolites in plasma and urine using automated solid phase extraction and fast gradient liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom 13:2305-2319.
  2. Indexed at, Google Scholar, Crossref

  3. Gautam N, Singh RP, Pratap R, Singh SK (2010) Liquid chromatographic-tandem mass spectrometry assay for quantitation of a novel antidiabetic S002-853 in rat plasma and its application to pharmacokinetic study. Biomed Chromatogr 24:692-698.
  4. Indexed at, Google Scholar, Crossref

  5. Mercolini L, Mandrioli R, Finizio G, Boncompagni G, Raggi MA (2010) Simultaneous HPLC determination of 14 tricyclic antidepressants and metabolites in human plasma. J Sep Sci 33:23-30.
  6. Indexed at, Google Scholar, Crossref

  7. Link B, Haschke M, Wenk M, Krahenbuhl S (2007) Determination of midazolam and its hydroxyl metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry. Rapid Commun Mass Spectrom 21:1531-1540.
  8. Indexed at, Google Scholar, Crossref

  9. Oostendrop RL, Beijnen JH, Schellens JH, Tellingen OV (2007) Determination of imatinib mesylate and its main metabolite (CGP74588) in human plasma and murine specimens by ionpairing reversed-phase high-performance liquid chromatography. Biomed Chromatogr 21:747-754.
  10. Indexed at, Google Scholar, Crossref

  11. Kavvadias D, Scherer G, Urban M, Cheung F, Errington G, Shepperd J, et al. (2009) Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 887:1185-1192.
  12. Indexed at, Google Scholar, Crossref

Citation: Chankvetadze B (2022) The use of Bioanalysis in Medication Development and Discovery. J Anal Bioanal Tech 10: 453. DOI: 10.4172/2155-9872.1000453

Copyright: © 2022 Chankvetadze B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top